Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance

J. Çoku, DM. Booth, J. Skoda, MC. Pedrotty, J. Vogel, K. Liu, A. Vu, EL. Carpenter, JC. Ye, MA. Chen, P. Dunbar, E. Scadden, TD. Yun, E. Nakamaru-Ogiso, E. Area-Gomez, Y. Li, KC. Goldsmith, CP. Reynolds, G. Hajnoczky, MD. Hogarty

. 2022 ; 41 (8) : e108272. [pub] 20220225

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018747

Grantová podpora
R01 CA216254 NCI NIH HHS - United States
R01 CA217251 NCI NIH HHS - United States
R01 CA221957 NCI NIH HHS - United States
R21 CA198430 NCI NIH HHS - United States

Most cancer deaths result from progression of therapy resistant disease, yet our understanding of this phenotype is limited. Cancer therapies generate stress signals that act upon mitochondria to initiate apoptosis. Mitochondria isolated from neuroblastoma cells were exposed to tBid or Bim, death effectors activated by therapeutic stress. Multidrug-resistant tumor cells obtained from children at relapse had markedly attenuated Bak and Bax oligomerization and cytochrome c release (surrogates for apoptotic commitment) in comparison with patient-matched tumor cells obtained at diagnosis. Electron microscopy identified reduced ER-mitochondria-associated membranes (MAMs; ER-mitochondria contacts, ERMCs) in therapy-resistant cells, and genetically or biochemically reducing MAMs in therapy-sensitive tumors phenocopied resistance. MAMs serve as platforms to transfer Ca2+ and bioactive lipids to mitochondria. Reduced Ca2+ transfer was found in some but not all resistant cells, and inhibiting transfer did not attenuate apoptotic signaling. In contrast, reduced ceramide synthesis and transfer was common to resistant cells and its inhibition induced stress resistance. We identify ER-mitochondria-associated membranes as physiologic regulators of apoptosis via ceramide transfer and uncover a previously unrecognized mechanism for cancer multidrug resistance.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018747
003      
CZ-PrNML
005      
20220804135052.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.15252/embj.2021108272 $2 doi
035    __
$a (PubMed)35211994
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Çoku, Jorida $u Cancer Biology Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
245    10
$a Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance / $c J. Çoku, DM. Booth, J. Skoda, MC. Pedrotty, J. Vogel, K. Liu, A. Vu, EL. Carpenter, JC. Ye, MA. Chen, P. Dunbar, E. Scadden, TD. Yun, E. Nakamaru-Ogiso, E. Area-Gomez, Y. Li, KC. Goldsmith, CP. Reynolds, G. Hajnoczky, MD. Hogarty
520    9_
$a Most cancer deaths result from progression of therapy resistant disease, yet our understanding of this phenotype is limited. Cancer therapies generate stress signals that act upon mitochondria to initiate apoptosis. Mitochondria isolated from neuroblastoma cells were exposed to tBid or Bim, death effectors activated by therapeutic stress. Multidrug-resistant tumor cells obtained from children at relapse had markedly attenuated Bak and Bax oligomerization and cytochrome c release (surrogates for apoptotic commitment) in comparison with patient-matched tumor cells obtained at diagnosis. Electron microscopy identified reduced ER-mitochondria-associated membranes (MAMs; ER-mitochondria contacts, ERMCs) in therapy-resistant cells, and genetically or biochemically reducing MAMs in therapy-sensitive tumors phenocopied resistance. MAMs serve as platforms to transfer Ca2+ and bioactive lipids to mitochondria. Reduced Ca2+ transfer was found in some but not all resistant cells, and inhibiting transfer did not attenuate apoptotic signaling. In contrast, reduced ceramide synthesis and transfer was common to resistant cells and its inhibition induced stress resistance. We identify ER-mitochondria-associated membranes as physiologic regulators of apoptosis via ceramide transfer and uncover a previously unrecognized mechanism for cancer multidrug resistance.
650    _2
$a apoptóza $7 D017209
650    _2
$a ceramidy $7 D002518
650    _2
$a mnohočetná léková rezistence $7 D018432
650    _2
$a lidé $7 D006801
650    12
$a mitochondrie $7 D008928
650    _2
$a mitochondriální membrány $7 D051336
650    12
$a neuroblastom $x farmakoterapie $7 D009447
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Booth, David M $u MitoCare Center, Department of Pathology, Anatomy & Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA
700    1_
$a Skoda, Jan $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $1 https://orcid.org/0000000292928177
700    1_
$a Pedrotty, Madison C $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
700    1_
$a Vogel, Jennifer $u Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
700    1_
$a Liu, Kangning $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
700    1_
$a Vu, Annette $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
700    1_
$a Carpenter, Erica L $u Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
700    1_
$a Ye, Jamie C $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
700    1_
$a Chen, Michelle A $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
700    1_
$a Dunbar, Peter $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
700    1_
$a Scadden, Elizabeth $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA $1 https://orcid.org/0000000282264944
700    1_
$a Yun, Taekyung D $u Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
700    1_
$a Nakamaru-Ogiso, Eiko $u Mitochondrial Medicine Frontier Program, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA $u Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
700    1_
$a Area-Gomez, Estela $u Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA $1 https://orcid.org/0000000209621570
700    1_
$a Li, Yimei $u Department of Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
700    1_
$a Goldsmith, Kelly C $u Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
700    1_
$a Reynolds, C Patrick $u TTUHSC Cancer Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA
700    1_
$a Hajnoczky, Gyorgy $u MitoCare Center, Department of Pathology, Anatomy & Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA $1 https://orcid.org/0000000338132570
700    1_
$a Hogarty, Michael D $u Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA $u Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA $1 https://orcid.org/0000000292214852
773    0_
$w MED00001509 $t The EMBO journal $x 1460-2075 $g Roč. 41, č. 8 (2022), s. e108272
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35211994 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135046 $b ABA008
999    __
$a ok $b bmc $g 1822388 $s 1169990
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 41 $c 8 $d e108272 $e 20220225 $i 1460-2075 $m EMBO journal $n EMBO J $x MED00001509
GRA    __
$a R01 CA216254 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA217251 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA221957 $p NCI NIH HHS $2 United States
GRA    __
$a R21 CA198430 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace